Eliquis

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
The 25 Most Popular Drugs by U.S. Spending
AARP
Fri, 05/10/24 - 11:33 am
prescription spending
Ozempic
Rybelsus
Wegovy
Eliquis
Humira
Novo Nordisk
AbbVie
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
Fierce Biotech
Mon, 11/20/23 - 11:41 am
Bayer
asundexian
bloodthinners
Eliquis
clinical trials
There's a Silver Lining in Pfizer's Dark Cloud
Motley Fool
Fri, 11/3/23 - 10:56 am
Pfizer
earnings
Eliquis
Ibrance
patents
Eliquis: the cardio drug that cannot be beat
EP Vantage
Fri, 08/4/23 - 10:14 am
Bristol Myers Squibb
Eliquis
generics
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026
Fierce Pharma
Thu, 03/30/23 - 10:59 am
Pfizer
Bristol Myers Squibb
Eliquis
drug pricing
Inflation Reduction Act
CMS
ESC 2022 preview – who’s got the XI factor?
EP Vantage
Tue, 08/23/22 - 10:23 am
ESC 2022
Bristol Myers Squibb
JNJ
Bayer
Eliquis
Xarelto
bloodthinners
Lixiana
Pradaxa
CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback
Fierce Pharma
Fri, 06/24/22 - 10:42 am
CVS Health
Bristol Myers Squibb
Pfizer
Eliquis
formularies
bloodthinners
Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report
Fierce Pharma
Tue, 06/14/22 - 08:57 pm
JNJ
Xarelto
Bristol Myers Squibb
Eliquis
drug pricing
blood thinners
FTC
The patent winter is coming
EP Vantage
Wed, 05/25/22 - 10:41 am
patents
biosimilars
patent cliff
Keytruda
Opdivo
Eliquis
Darzalex
Revlimid
Humira
Stelara
AbbVie
Merck
Bristol Myers Squibb
JNJ
Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race
Endpoints
Mon, 04/4/22 - 10:56 am
Bayer
bloodthinners
asundexian
clinical trials
Eliquis
Bristol Myers Squibb
JNJ
JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid's patent cliff
Fierce Pharma
Mon, 01/10/22 - 11:49 pm
JPMHC 2022
Bristol Myers Squibb
Revlimid
patent cliffs
Opdivo
Eliquis
Reblozyl
Breyanzi
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Fierce Pharma
Fri, 12/31/21 - 11:10 am
patents
patent cliffs
Bristol Myers Squibb
Amgen
Pfizer
Revlimid
Eliquis
Enbrel
Otezla
Ibrance
Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028
Fierce Pharma
Tue, 09/7/21 - 10:43 pm
Bristol Myers Squibb
Pfizer
Eliquis
patents
FTC
J&J, Bayer's Xarelto scores FDA nod in post-surgery artery disease as partners try to catch up with Eliquis
Fierce Pharma
Tue, 08/24/21 - 10:54 pm
Pfizer
Bristol Myers Squibb
Bayer
JNJ
Xarelto
FDA
Eliquis
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Eliquis partners BMS and Pfizer join the pharma crowd urging doctor visits during COVID-19
Fierce Pharma
Mon, 11/2/20 - 10:29 am
Pfizer
Bristol-Myers Squibb
Eliquis
DTC advertising
pandemic
COVID-19
ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study
Fierce Pharma
Mon, 08/31/20 - 10:49 am
Pfizer
Bristol-Myers Squibb
Eliquis
Xarelto
site-specific bleeding
RWE
ESC

Pages